Capio Psykiatri AB
Stockholm, 136 40, Sweden
NCT Number: NCT02889354
The newly developed CBT for ADHD inattentive-type (ADHD-I) protocol is tested for feasibility and acceptability in a pilot study with a single group design. The study also evaluates measurements and recruiting possibilities, and effects of the intervention. Research hypotheses include: 1. There is a basis for recruiting ADHD-I patients for participation in an RCT at psychiatric outpatient units, 2. The measurements in the study are feasible and reasonable in regards to patient characteristics; that is, the patients are responding to the questionnaires as intended, 3. The CBT for ADHD-I intervention is feasible in terms of treatment completion, compliance to home assignments, and credibility and relevance, and is lacking of or involves a tolerable degree of adverse effects, and 4. The CBT for ADHD-I protocol reduces core symptoms of ADHD-I as well as symptoms of stress, depression, and anxiety, and improves quality of life.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Stockholm, 136 40, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
In addition to an ADHD inattentive-type diagnosis, inclusion criteria are:
Exclusion criteria
Time frame: 14 weeks
Diagnostic measure
Karolinska Institutet
Other
Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type: a Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01876524
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Cartagena, Murcia, Spain
View Trial DetailsNCT06679010
Anxiety, Anxiety Disorders
Odense, Denmark
View Trial DetailsNCT02364817
Alcohol-Related Disorders, Alcoholism
Bron, France
View Trial DetailsNCT07253441
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Lenexa, Kansas, United States
View Trial Details